Capstone Investment Advisors, LLC Invitae Corp Transaction History
Capstone Investment Advisors, LLC
- $51.1 Billion
- Q3 2025
A detailed history of Capstone Investment Advisors, LLC transactions in Invitae Corp stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 10,000 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVTA
# of Institutions
19Shares Held
1.69MCall Options Held
0Put Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA1.28MShares$02.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ158KShares$00.0% of portfolio
-
Eaton Vance Management Boston, MA100KShares$00.0% of portfolio
-
Rayliant Investment Research Santa Monica, CA50.4KShares$00.09% of portfolio
-
American Portfolios Advisors Holbrook, NY47.8KShares$00.0% of portfolio
About Invitae Corp
- Ticker NVTA
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 235,266,000
- Description
- Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...